This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Anne B. Fulton, MD; Michael E. Breton, PhD

Arch Ophthalmol. 1993;111(11):1479-1481.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THIS IS a new era in which gene mutations are beginning to redefine the heritable photoreceptor disorders and bring hope of new treatments. Studies of molecular mechanisms in the living eyes of patients are needed to transform the exciting genetic information into benefit to patients. The stage for patient studies has been set by (1) molecular genetics and biology and (2) the development of techniques for noninvasive studies of molecular events in photoreceptor outer segments. There is an unprecedented opportunity to advance the understanding of the heritable diseases of photoreceptors and gain insights that will lead to treatment, perhaps cure.

In 1990, only 6 years after the human rhodopsin gene was cloned,¹ a mutation of that gene was reported in patients with autosomal dominant retinitis pigmentosa.² Since then, more than four dozen mutations of the human rhodopsin gene have been identified in patients with retinitis pigmentosa. Besides rhodopsin, . . . [Full Text PDF of this Article]

Author Affiliations
Boston, Mass; Philadelphia, Pa

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?